CME Group Inc. (NASDAQ:CME) Shares Bought by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. increased its position in CME Group Inc. (NASDAQ:CME) by 1.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 552,108 shares of the financial services provider’s stock after acquiring an additional 7,525 shares during the period. Envestnet Asset Management Inc.’s holdings in CME Group were worth $128,216,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. SJS Investment Consulting Inc. boosted its position in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares during the period. Dunhill Financial LLC raised its stake in shares of CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares in the last quarter. New Age Alpha Advisors LLC lifted its holdings in CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 43 shares during the period. Financial Life Planners bought a new position in CME Group in the 4th quarter valued at about $32,000. Finally, Knuff & Co LLC acquired a new position in CME Group during the 4th quarter valued at about $33,000. 87.75% of the stock is currently owned by institutional investors.

Insider Activity at CME Group

In related news, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares of the company’s stock, valued at approximately $2,063,885.88. The trade was a 15.73 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the sale, the director now owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 27,076 shares of company stock valued at $6,871,496. Company insiders own 0.30% of the company’s stock.

CME Group Price Performance

CME stock opened at $252.37 on Tuesday. The firm has a 50-day moving average of $252.91 and a two-hundred day moving average of $237.72. The firm has a market capitalization of $90.94 billion, a PE ratio of 26.10, a P/E/G ratio of 6.76 and a beta of 0.43. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a one year low of $190.70 and a one year high of $273.42.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were issued a dividend of $1.25 per share. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.98%. CME Group’s payout ratio is currently 51.71%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on CME shares. Royal Bank of Canada reiterated a “sector perform” rating and issued a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. Bank of America increased their price target on CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a research note on Wednesday, April 2nd. Piper Sandler boosted their price objective on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. JPMorgan Chase & Co. upped their price objective on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Finally, Morgan Stanley lifted their target price on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 19th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and an average target price of $242.60.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.